Product image of Metypred (Methylprednisolone) supplied by GNH India

Metypred

Active Ingredient:
Methylprednisolone
Origin:
EU

Metypred (Methylprednisolone)

Methylprednisolone, the active ingredient in Metypred, is a glucocorticoid presented as an oral dosage form for systemic use. Approved in the European Union, it is prescribed to reduce inflammation and modulate immune responses in a variety of inflammatory, allergic, dermatologic, respiratory and rheumatic conditions.\n\nGNH India supplies Metypred as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and transplant centres worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metypred, a glucocorticoid, is employed across several disease families to control inflammation and immune activity.\n\n- Inflammatory and autoimmune disorders: Reduces tissue inflammation and suppresses pathological immune responses.\n- Allergic reactions: Diminishes acute and chronic allergic inflammation, relieving symptoms such as swelling and itching.\n- Dermatologic conditions: Controls severe skin inflammation in diseases like psoriasis and dermatitis.\n- Respiratory diseases: Improves airflow and reduces exacerbations in asthma and COPD.\n- Rheumatic diseases: Alleviates joint pain and swelling in conditions such as rheumatoid arthritis.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and interacts with glucocorticoid response elements on DNA. This modulates transcription of anti‑inflammatory proteins while repressing pro‑inflammatory cytokine genes, leading to decreased leukocyte migration, reduced capillary permeability, and overall suppression of immune activity.

Side Effects

  • Methylprednisolone may cause a range of adverse reactions that vary in frequency and severity.\n\nCommon Side Effects:\n- Increased appetite and weight gain\n- Insomnia or mood changes\n- Elevated blood glucose levels\n- Gastrointestinal discomfort or ulceration\n- Fluid retention and mild hypertension\n\nSerious or Rare Side Effects:\n- Adrenal insufficiency on abrupt discontinuation\n- Severe or opportunistic infections\n- Osteoporosis and increased fracture risk\n- Psychosis or severe mood disturbances\n- Cushingoid appearance with prolonged use\n- Anaphylaxis or severe hypersensitivity reactions

Precautions & Warnings

  • When prescribing Metypred, clinicians should consider several safety measures.\n\n- Assess infection risk: screen for active infections before initiation.\n- Monitor blood glucose: patients with diabetes may require dose adjustments.\n- Taper therapy: gradually reduce dose when discontinuing long‑term treatment.\n- Avoid abrupt cessation: sudden stop can precipitate adrenal crisis.\n- Use lowest effective dose: limit exposure to reduce adverse effects.\n- Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

  • Methylprednisolone can interact with other medicines, influencing efficacy or safety.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure.\n- Live vaccines: heightened risk of severe infection.\n- Anticoagulants (e.g., warfarin): enhanced anticoagulant effect.\n\nModerate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory drugs: increased gastrointestinal bleeding risk.\n- Diuretics: may exacerbate hypokalemia.\n- Antidiabetic agents: may require dose reduction due to hyperglycaemic effect.

Frequently Asked Questions

Metypred contains methylprednisolone, a glucocorticoid used to treat a range of inflammatory and immune‑mediated conditions such as severe asthma, rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain skin disorders. It works by dampening the body’s inflammatory response and reducing immune system activity.

Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that enters the nucleus and alters gene transcription. This up‑regulates anti‑inflammatory proteins while down‑regulating pro‑inflammatory cytokines, leading to reduced leukocyte migration, decreased capillary permeability, and overall suppression of immune activity.

The appropriate dose of Metypred is determined by the prescribing clinician based on the specific condition, severity, patient weight, and response to therapy. Dosage regimens can vary widely, and any adjustments should be made under medical supervision.

Safety data for methylprednisolone during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order Metypred, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Methylprednisolone is a medium‑to‑high potency glucocorticoid with a relatively rapid onset and a half‑life of about 18‑36 hours, positioning it between prednisone (lower potency) and dexamethasone (higher potency). It offers strong anti‑inflammatory effects while allowing flexible dosing schedules, making it suitable for acute exacerbations and chronic management.

Metypred should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources.

Metypred is taken orally. The tablet should be swallowed whole with a glass of water and can be taken with or without food, unless the prescribing physician advises otherwise. The exact timing and frequency are determined by the treating clinician.

Serious risks include adrenal insufficiency, especially after abrupt discontinuation; severe or opportunistic infections; significant hyperglycaemia; osteoporosis with long‑term use; and psychiatric effects such as mood swings, depression, or psychosis. Patients should be monitored regularly for these complications.

Metypred is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and in those with systemic fungal infections that require systemic therapy. Caution is also advised for individuals with uncontrolled diabetes, active peptic ulcer disease, or severe hypertension, and it should be avoided in these contexts unless benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT